Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

2.

Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.

Pham PT, Heydrick SJ, Fox HL, Kimball SR, Jefferson LS Jr, Lynch CJ.

J Cell Biochem. 2000 Sep 7;79(3):427-41.

PMID:
10972980
4.
5.

Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes.

Scott PH, Lawrence JC Jr.

J Biol Chem. 1998 Dec 18;273(51):34496-501.

6.

A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Sekulić A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT.

Cancer Res. 2000 Jul 1;60(13):3504-13.

7.

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.

Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J.

J Biol Chem. 1998 Jun 5;273(23):14484-94. Erratum in: J Biol Chem 1998 Aug 21;273(34):22160.

9.

FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions.

Peterson RT, Beal PA, Comb MJ, Schreiber SL.

J Biol Chem. 2000 Mar 10;275(10):7416-23.

10.
11.
12.

Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).

Dickson LM, Lingohr MK, McCuaig J, Hugl SR, Snow L, Kahn BB, Myers MG Jr, Rhodes CJ.

J Biol Chem. 2001 Jun 15;276(24):21110-20. Epub 2001 Mar 27.

13.

In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.

Pellegatta F, Catapano AL, Luzi L, Terruzzi I.

J Cardiovasc Pharmacol. 2006 May;47(5):643-9.

PMID:
16775502
14.
16.

hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.

Byfield MP, Murray JT, Backer JM.

J Biol Chem. 2005 Sep 23;280(38):33076-82. Epub 2005 Jul 27.

17.

A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.

Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, Kemp BE, Witters LA, Mimura O, Yonezawa K.

Genes Cells. 2003 Jan;8(1):65-79.

18.

Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways.

Gerasimovskaya EV, Tucker DA, Weiser-Evans M, Wenzlau JM, Klemm DJ, Banks M, Stenmark KR.

J Biol Chem. 2005 Jan 21;280(3):1838-48. Epub 2004 Nov 1.

19.

Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.

Park IH, Bachmann R, Shirazi H, Chen J.

J Biol Chem. 2002 Aug 30;277(35):31423-9. Epub 2002 Jun 26.

20.

Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity.

Varma S, Shrivastav A, Changela S, Khandelwal RL.

Exp Cell Res. 2008 Apr 1;314(6):1281-91. doi: 10.1016/j.yexcr.2007.12.019. Epub 2008 Jan 5.

PMID:
18261725

Supplemental Content

Support Center